Ligand profile
NDN
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02286 — Thymidylate synthase
Identifiers
Database identifiers and provenance.
- Ligand ID
NDN- PDB
3b5b- UniProt (similar protein)
P0A884- Target protein
- KP13_02286
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 194.2
- −1 ≤ LogP ≤ 5 -1.80
- MW ≤ 500 Da 353.2
- LogP ≤ 5 -1.80
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 194.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)[N+](=O)[O-])COP(=O)(O)O)OC1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)[N+](=O)[O-])COP(=O)(O)O)O
InChI=1S/C9H12N3O10P/c13-5-1-7(22-6(5)3-21-23(18,19)20)11-2-4(12(16)17)8(14)10-9(11)15/h2,5-7,13H,1,3H2,(H,10,14,15)(H2,18,19,20)/t5-,6+,7+/m0/s1InChI=1S/C9H12N3O10P/c13-5-1-7(22-6(5)3-21-23(18,19)20)11-2-4(12(16)17)8(14)10-9(11)15/h2,5-7,13H,1,3H2,(H,10,14,15)(H2,18,19,20)/t5-,6+,7+/m0/s1
LVLPVLNNXRTCHP-RRKCRQDMSA-NLVLPVLNNXRTCHP-RRKCRQDMSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00303
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NDN →
- PDB RCSB structure 3b5b →
- UniProt UniProt P0A884 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NDN”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02286.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).